DE69202653D1 - 2-Piperidinecarboxylicsäurederivate, Oncogene-Suppressor, Mittel und Reagenz zur Gewinnung von Revertanten. - Google Patents

2-Piperidinecarboxylicsäurederivate, Oncogene-Suppressor, Mittel und Reagenz zur Gewinnung von Revertanten.

Info

Publication number
DE69202653D1
DE69202653D1 DE69202653T DE69202653T DE69202653D1 DE 69202653 D1 DE69202653 D1 DE 69202653D1 DE 69202653 T DE69202653 T DE 69202653T DE 69202653 T DE69202653 T DE 69202653T DE 69202653 D1 DE69202653 D1 DE 69202653D1
Authority
DE
Germany
Prior art keywords
piperidinecarboxylic acid
revertants
reagent
obtaining
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69202653T
Other languages
English (en)
Other versions
DE69202653T2 (de
Inventor
Tsuneo Ikonogi
Osamu Makabe
Yuichi Yamamoto
Osamu Itoh
Tsutomu Tsuruoka
Takayuki Usui
Seiji Shibahara
Kozo Nagaoka
Shigeharu Inouye
Nobuko Okada
Susumu Nishimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP22919091A external-priority patent/JPH0565225A/ja
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Application granted granted Critical
Publication of DE69202653D1 publication Critical patent/DE69202653D1/de
Publication of DE69202653T2 publication Critical patent/DE69202653T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69202653T 1991-08-29 1992-08-28 2-Piperidinecarboxylicsäurederivate, Oncogene-Suppressor, Mittel und Reagenz zur Gewinnung von Revertanten. Expired - Fee Related DE69202653T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21902291 1991-08-29
JP22919091A JPH0565225A (ja) 1991-09-09 1991-09-09 発癌遺伝子抑制剤及び復帰突然変異細胞取得剤

Publications (2)

Publication Number Publication Date
DE69202653D1 true DE69202653D1 (de) 1995-06-29
DE69202653T2 DE69202653T2 (de) 1995-12-21

Family

ID=26522874

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69202653T Expired - Fee Related DE69202653T2 (de) 1991-08-29 1992-08-28 2-Piperidinecarboxylicsäurederivate, Oncogene-Suppressor, Mittel und Reagenz zur Gewinnung von Revertanten.

Country Status (8)

Country Link
US (1) US5334723A (de)
EP (1) EP0529655B1 (de)
KR (1) KR930004264A (de)
AT (1) ATE123021T1 (de)
CA (1) CA2077025A1 (de)
DE (1) DE69202653T2 (de)
DK (1) DK0529655T3 (de)
ES (1) ES2089318T3 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2594167B2 (ja) * 1990-05-21 1997-03-26 明治製菓株式会社 新規抗生物質sf2698物質およびその製造法

Also Published As

Publication number Publication date
DE69202653T2 (de) 1995-12-21
KR930004264A (ko) 1993-03-22
DK0529655T3 (da) 1995-08-07
EP0529655A1 (de) 1993-03-03
ES2089318T3 (es) 1996-10-01
EP0529655B1 (de) 1995-05-24
ATE123021T1 (de) 1995-06-15
CA2077025A1 (en) 1993-03-01
US5334723A (en) 1994-08-02

Similar Documents

Publication Publication Date Title
GB9401460D0 (en) Compositions of matter
DE122011100040I1 (de) Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivitat und zur behandlungvon tumoren.
UA48937C2 (uk) Імідазолідини, заміщені гетероциклом, спосіб їх одержання і фармацевтична композиція, що їх містить
AU576887B2 (en) 1,6-naphthyridine derivatives
DE69202653D1 (de) 2-Piperidinecarboxylicsäurederivate, Oncogene-Suppressor, Mittel und Reagenz zur Gewinnung von Revertanten.
DE69319939D1 (de) Aminobenzoesäure Derivate
DE3866148D1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
EP0399626A3 (en) Substituted tetrahydroisoquinoline compounds, their production, and pharmaceutical compositions containing them
ES451513A2 (es) Procedimiento para la preparacion de eteres y cetonas 2-car-balcoxiamino-bencimidazolil-5 (6)-fenilicos sustituidos con radicales basicos.
ES460694A1 (es) Procedimiento para la obtencion de 2-piperidino alquil-(1- benzofuranos o 1,4-benzodioxanos).
ZA200100566B (en) Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines.
EP0177361A3 (de) Octahydroindolo-[2,3-a]chinolizin-1-yl-alkane-carboxylsäure Amide und seine Salze
ES454098A1 (es) Procedimiento para producir argininamidas y sus sales.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee